Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Elevated Initial APRI Value Was Associated With the Development of Sepsis-associated Liver Dysfunction in Adult Patients With Sepsis

NCT05999331 is registered in ClinicalTrials.gov with Chinese Medical Association as lead sponsor.

NCT NCT05999331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05999331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Elevated Initial APRI Value Was Associated With the Development of Sepsis-associated Liver Dysfunction in Adult Patients With Sepsis
Lead sponsor
Chinese Medical Association
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2019
Completion date
September 30, 2023
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver dysfunction, sepsis-associated liver dysfunction